Shirasawa Masayuki 白澤昌之

… Alternative Names

白澤昌之シラサワマサユキ

Less

Researcher Number	40898996
Affiliation (Current)	2025: 北里大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2023: 北里大学, 医学部, 助教 2021 – 2022: 国立研究開発法人国立がん研究センター, 中央病院, がん専門修練医
Review Section/Research Field	Except Principal Investigator Basic Section 53030:Respiratory medicine-related / Basic Section 49020:Human pathology-related
Keywords	Except Principal Investigator 免疫療法 / 小細胞肺癌 / 神経内分泌分化 / 免疫チェックポイント阻害剤 / 小細胞肺がん / AI病理学 / デジタル病理学 / 病理組織 / 治療効果予測 / 形態学的バイオマーカー

SCLC subtyping as a predictor of therapeutic response to immunotherapy
- Principal Investigator
  
  吉田達哉
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  National Cancer Center Japan
Development study on pathological predictive biomarkers for cancer treatment
- Principal Investigator
  
  元井紀子
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Research Institute for Clinical Oncology Saitama Cancer Center

All 2023 2022 2021

All Journal Article Presentation

[Journal Article] Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy2023
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Shiraishi Kouya、et al.
- Journal Title
  
  Lung Cancer
  
  Volume: 179 Pages: 107183-107183
- DOI
  10.1016/j.lungcan.2023.107183
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20H03695, KAKENHI-PROJECT-21K19492, KAKENHI-PROJECT-23K07615, KAKENHI-PROJECT-20K17668
[Journal Article] Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer2023
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Shiraishi Kouya、Yagihita Shigehiro、Ohe Yuichiro et al.
- Journal Title
  
  British Journal of Cancer
  
  Volume: 129 Issue: 12 Pages: 2003-2013
- DOI
  10.1038/s41416-023-02427-3
- Data Source
  KAKENHI-PROJECT-23K07615
[Journal Article] Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma2023
- Author(s)
  Higashiyama Masahiro、Motoi Noriko、Yotsukura Masaya、Yoshida Yukihiro、Nakagawa Kazuo、Yagishita Shigehiro、Shirasawa Masayuki、Yoshida Tatsuya、Shiraishi Kouya、Kohno Takashi、Ohe Yuichiro、Watanabe Shun‐ichi
- Journal Title
  
  Pathology International
  
  Volume: 73 Issue: 5 Pages: 188-197
- DOI
  10.1111/pin.13316
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06900, KAKENHI-PROJECT-20H03695, KAKENHI-PROJECT-21K19492, KAKENHI-PROJECT-20H00545
[Journal Article] Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients2022
- Author(s)
  Shimoda Yukiko、Shibaki Ryota、Yoshida Tatsuya、Murakami Shuji、Shirasawa Masayuki、Torasawa Masahiro、Matsumoto Yuji、Masuda Ken、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Yamamoto Noboru、Ohe Yuichiro、Motoi Noriko
- Journal Title
  
  Clinical Lung Cancer
  
  Volume: 23 Issue: 6 Pages: 477-486
- DOI
  10.1016/j.cllc.2022.04.001
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K06900
[Journal Article] Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer2022
- Author(s)
  Shirasawa Masayuki、Yoshida Tatsuya、Imabayashi Tatsuya、Okuma Kae、Matsumoto Yuji、Masuda Ken、Shinno Yuki、Okuma Yusuke、Goto Yasushi、Horinouchi Hidehito、Tsuchida Takaaki、Yamamoto Noboru、Nakayama Yuko、Watanabe Shun-ichi、Motoi Noriko、Ohe Yuichiro
- Journal Title
  
  European Journal of Cancer
  
  Volume: 162 Pages: 1-10
- DOI
  10.1016/j.ejca.2021.11.013
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07036, KAKENHI-PROJECT-21K06900
[Presentation] 神経内分泌腫瘍の診断と治療　進行/再発肺大細胞神経内分泌癌における,Pd-1阻害剤の効果と腫瘍免疫微小環境との関連についての検討,2021
- Author(s)
  白澤昌之, 吉田達哉, 関根克敏, 神田慎太郎, 松元祐司, 増田健, 新野祐樹, 大熊裕介, 後藤悌, 堀之内秀仁, 山本昇, 渡辺俊一, 元井紀子, 大江裕一郎.
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-21K06900

1. 吉田達哉 (10729338)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
2. 元井紀子 (70292878)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. 石井源一郎 (00270869)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 大江裕一郎 (20233041)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
5. 田丸淳一 (30188429)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 青木一教 (60270675)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 吉田裕 (70750751)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
8. 河野隆志 (80280783)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
9. 渡辺俊一 (80303303)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
10. 浜本隆二 (80321800)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 神田浩明 (90260067)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. 白石航也 (80609719)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
13. 柳下薫寛 (80781674)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Shirasawa Masayuki 白澤 昌之

白澤 昌之 シラサワ マサユキ

Research Projects

Research Products

Co-Researchers

SCLC subtyping as a predictor of therapeutic response to immunotherapy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development study on pathological predictive biomarkers for cancer treatment

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer2022

Author(s)

Journal Title

DOI

Data Source

[Presentation] 神経内分泌腫瘍の診断と治療 進行/再発肺大細胞神経内分泌癌における,Pd-1阻害剤の効果と腫瘍免疫微小環境との関連についての検討,2021

Author(s)

Organizer

Data Source

Shirasawa Masayuki 白澤昌之

白澤昌之シラサワマサユキ

[Presentation] 神経内分泌腫瘍の診断と治療　進行/再発肺大細胞神経内分泌癌における,Pd-1阻害剤の効果と腫瘍免疫微小環境との関連についての検討,2021